Mainstay Medical International plc: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

DUBLIN--()--Regulatory News:

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

1   Details of the person discharging managerial responsibilities/person closely associated
a) Name   Mr Greg Garfield
 
2 Reason for the notification
a) Position/status Non-executive director
b) Initial Notification Amendment Initial Notification
 
3

Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor

a) Name

Mainstay Medical International plc (the “Company”)

b) LEI 635400IUPSOZ26H56Y03
 
4

Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument,

type of

instrument

Identification code

Ordinary Shares of nominal value of €0.001 each in the Company, ISIN: IE00BJYS1G50
b) Nature of the transaction Subscription for ordinary shares
c) Price(s) and volume(s)

Price   
€14 per Ordinary Share

 

Volume
2,912 Ordinary Shares

 

d) Aggregated information

— Aggregated volume

— Price

Total price of the transaction: €40,768 (forty thousand, seven hundred and six- eight euro)
e) Date of the transaction 15 February 2018
f) Place of the transaction Outside a trading venue
g) Additional Information N/A

Contacts

FTI Consulting for Mainstay Medical
Jonathan Neilan
+353-1-663-3686
Jonathan.Neilan@fticonsulting.com

Contacts

FTI Consulting for Mainstay Medical
Jonathan Neilan
+353-1-663-3686
Jonathan.Neilan@fticonsulting.com